Cytotoxic biotransformed products from cinobufagin by Mucor spinosus and Aspergillus niger

被引:40
作者
He, XJ [1 ]
Tang, JS
Qiao, AM
Wang, GH
Jiang, MM
Liu, RH
Yao, XS
机构
[1] Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Guangzhou 510632, Peoples R China
[2] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA
[3] Shenyang Pharmaceut Univ, Dept Nat Prod Chem, Shenyang 110016, Peoples R China
[4] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang 110016, Peoples R China
基金
中国国家自然科学基金;
关键词
steroid microbial conversion; cinobufagin; Mucor spinosus; Aspergillus niger; anticancer activities;
D O I
10.1016/j.steroids.2005.12.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cinobufagin (1) was one of important cardenolidal steroids and major components of Chan'Su, a famous traditional Chinese medicine. Bioconversion of cinobufagin by the fungi of Mucor spinosus and Aspergillus niger were investigated. Nine bioconversion products were obtained from M. spinosus and seven products from A. niger. Their structures were elucidated by high-resolution fast atom bombardment mass spectroscopy (HR-FAB-MS), extensive NMR techniques, including H-1 NMR, C-13 NMR, DEPT, H-1-H-1 correlation spectroscopy (COSY), two-dimensional nuclear Overhauser effect correlation spectroscopy (NOESY), heteronuclear multiple quantum coherence (HMQC) and heteronuclear multiple bond coherence (HMBC). The in vitro cytotoxic activities against human hepatoma cells (HepG2, SMMC-7221 and BEL-7402) and human leukemia cells (K562, HL-60 and HEL) of all bioconversion products were determined by the MTT method, and their structure-activity relationships (SAR) were discussed. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:392 / 402
页数:11
相关论文
共 30 条
  • [1] CARMICHAEL J, 1987, CANCER RES, V47, P936
  • [2] Microbial conversion of steroid compounds: recent developments
    Fernandes, P
    Cruz, A
    Angelova, B
    Pinheiro, HM
    Cabral, JMS
    [J]. ENZYME AND MICROBIAL TECHNOLOGY, 2003, 32 (06) : 688 - 705
  • [3] STUDIES ON PLANT-TISSUE CULTURES .55. BIOTRANSFORMATION OF DIGITOXIGENIN BY CELL-SUSPENSION CULTURES OF STROPHANTHUS-GRATUS
    FURUYA, T
    KAWAGUCHI, K
    HIROTANI, M
    [J]. PHYTOCHEMISTRY, 1988, 27 (07) : 2129 - 2133
  • [4] Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs
    Hashimoto, S
    Jing, YK
    Kawazoe, N
    Masuda, Y
    Nakajo, S
    Yoshida, T
    Kuroiwa, Y
    Nakaya, K
    [J]. LEUKEMIA RESEARCH, 1997, 21 (09) : 875 - 883
  • [5] SIMULTANEOUS DETERMINATION OF BUFADIENOLIDES IN THE TRADITIONAL CHINESE MEDICINE PREPARATION, LIU-SHEN-WAN, BY LIQUID-CHROMATOGRAPHY
    HONG, Z
    CHAN, K
    YEUNG, HW
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 (12) : 1023 - 1026
  • [6] QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/51
    Kamano, Y
    Yamashita, A
    Nogawa, T
    Morita, H
    Takeya, K
    Itokawa, H
    Segawa, T
    Yukita, A
    Saito, K
    Katsuyama, M
    Pettit, GR
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (25) : 5440 - 5447
  • [7] Structure-cytotoxic activity relationship for the toad poison bufadienolides
    Kamano, Y
    Kotake, A
    Hashima, H
    Inoue, M
    Morita, H
    Takeya, K
    Itokawa, H
    Nandachi, N
    Segawa, T
    Yukita, A
    Saitou, K
    Katsuyama, M
    Pettit, GR
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (07) : 1103 - 1115
  • [8] MIZUTANI Y, 1995, CANCER RES, V55, P590
  • [9] Screening of natural compounds for inhibitory activity on colon cancer cell migration
    Ogasawara, M
    Matsubara, T
    Suzuki, H
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (06) : 720 - 723
  • [10] ROSAZZA JPN, 1986, ALKALOIDS CHEM PHARM, V27, P391